Medical Marijuana, Inc. and Subsidiary Kannaway® Announce March 2018 as the Largest Revenue Sales Month in Company History

SAN DIEGO, April 4, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that both the Company and its subsidiary Kannaway® booked the largest-ever (unaudited) sales revenue in its history in March of 2018, as well as reached major milestones in its business operations.
“March, 2018 was the largest revenue month in the history of our Company.  We look forward to sharing our full 2017 results in our Annual Report which will be filed this month,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus.
Medical Marijuana, Inc. experienced many accomplishments in March 2018 including co-hosting the first-ever hospital cannabis events in Brazil, its subsidiary Dixie Botanicals launching new Energy Kick flavors, and obtaining positive news coverage in several national and international publications including CBS’ The Doctors, The Washington Post, Epicurious, Glam and more.
“Kannaway has gained a significant amount of momentum,” said Kannaway® CEO Blake Schroeder. “March marked two years since Kannaway’s re-branding initiative and over the course of that time Kannaway has grown nearly 40 times in revenue. We are very much looking forward to many major launches as we host our Empower National Convention in Las Vegas this April.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit
To see Medical Marijuana, Inc.’s corporate video, click here.
Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Andrew Hard
Chief Executive Officer CMW Media
P. 858-264-6600
The post Medical Marijuana, Inc. and Subsidiary Kannaway® Announce March 2018 as the Largest Revenue Sales Month in Company History appeared first on Medical Marijuana, Inc..

Go to Source

Powered by WPeMatico